- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06292325
Psychological Aspects in OSA (PSICOSA)
Psychological Aspects in Modifying Apnea/Hypopnea Indices and Nadir of Saturation in Obstructive Sleep Apnea Syndrome (OSA)
The research project consists of an observational study. Obstructive Sleep Apnea (OSA) is a condition characterized by recurrent episodes of upper airway collapse during sleep, leading to decreased blood oxygen levels and disruptions of normal sleep patterns. Estimates of its prevalence vary, but its impact on patients' quality of life is evident.
Through a qualitative analysis (semi-structured interviews for both patients and bed partners) and a quantitative analysis (APIM Model), this research aims to explore the perception and awareness of the disease and its impact on the individual and couple's lives of patients with OSA and their bed partners, to assess patients' perceptions of the disease, illness management (CPAP experience) and symptoms, as well as their bed partners' perceptions. Moreover, psychological aspects of living with OSA, such as perceived stress, depression, anxiety, sleep quality, daily sleepiness will be studied to observe the association with Continuous Positive Airway Pressure (CPAP) adherence.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Firstly, a series of semi-structured interviews will be conducted with patients with OSA, at different levels of CPAP adaptation as well as with bed partners of patients who are experiencieng CPAP treatment with OSA.
After that, a quantitative analysis will be conducted to explore dyadic dynamics between patients with OSA and their bed partners.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
MI
-
Milan, MI, Italy, 20148
- IRCCS Fondazione Don Carlo Gnocchi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult outpatient patients
- over 18 years of age
- Diagnosis of Obstructive Sleep Apnea Syndrome
- Absence of cognitive impairments
- Having a bedpartner
Exclusion Criteria:
- Oncological comorbidities
- Dementia, as reported in the medical record
- Ongoing treatment with phosphodiesterase-5 inhibitors, hypogonadism, or severe lung diseases
- Exacerbations requiring hospitalization or the use of corticosteroids and antibiotics in the last two months
- Lack of consent
- Lack of a bedpartner
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Illness Perception Questionnaire (Brief IPQ)
Time Frame: from May 2023 to May 2024
|
It is a self-administered questionnaire consisting of nine items rated on a scale of 0-10.
The first five items assess cognitive perceptions such as the impact on life (item 1); duration of illness (item 2); disease control (item 3); beliefs about treatment effectiveness (item 4); and symptom experience (item 5).
Items 6 and 8 assess emotional aspects, such as concern about the illness and mood.
Item 7 assesses the level of understanding of the illness.
The last item requires respondents to rank the three factors that caused the illness.
Cut-offs for the total score are determined as follows: <42 indicates a mild threat, 42-49 indicates a moderate threat, and ≥50 indicates a high threat.
|
from May 2023 to May 2024
|
|
CPAP therapy adherence (hours/night)
Time Frame: from May 2023 to May 2024
|
CPAP therapy average daily adherence will be evaluated through data extraction from the integrated ventilator software during hospital visits.
|
from May 2023 to May 2024
|
|
Dyadic Adjustment Scale (DAS)
Time Frame: from May 2023 to May 2024
|
A self-administered questionnaire consisting of 32 items divided into 4 subscales: "Consensus on important issues," "Satisfaction with relationship status," "Doing things together," and "Satisfaction with emotional and sexual life."
To obtain the interpretation of the questionnaire, the average score for each area is calculated, noting that in the responses to questions 30 and 31, the corresponding score is 0 for NO and 1 for YES.
|
from May 2023 to May 2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The experience in close relationships-revised (ECR-R) Scale
Time Frame: from May 2023 to May 2024
|
It is a self-administered questionnaire, consisting of two subscales of 18 items each, which assess Avoidance and Anxiety related to attachment in relationships with romantic partners.
The items are rated on a 7-point Likert scale (1=strongly disagree; 7=strongly agree), with higher scores indicating greater attachment avoidance and anxious attachment with romantic partners.
|
from May 2023 to May 2024
|
|
The Psychological General Well-Being Index (PGWB-S)
Time Frame: from May 2023 to May 2024
|
The short version with 6 items of the self-administered questionnaire composed of 22 items, which provides a subjective assessment of one's psychological well-being, on a 6-step Likert scale (0-5).
Higher scores indicate greater psychological well-being.
|
from May 2023 to May 2024
|
|
The Patient Health Questionnaire - 9 (PHQ-9)
Time Frame: from May 2023 to May 2024
|
It consists of 9 items corresponding to symptoms of major depression according to the DSM-IV.
Scores range from 0 to 27.
Scores between 0 and 9 indicate subthreshold depression.
A score of 10 is identified as the point where the sensitivity and specificity of the instrument are recognized as optimal for detecting clinically significant depression.
|
from May 2023 to May 2024
|
|
The Generalized Anxiety Scale -7 (GAD-7)
Time Frame: from May 2023 to May 2024
|
It's a 7 items scale, designed to assess the severity of generalized anxiety disorder symptoms.
Comprising seven items that inquire about common anxiety symptoms such as feeling nervous, worrying excessively, and experiencing restlessness.
Each item on the scale is scored on a Likert scale ranging from 0 to 3, with responses indicating the frequency of symptoms over the past two weeks.
The total score ranges from 0 to 21, with higher scores indicating greater severity of anxiety symptoms.
|
from May 2023 to May 2024
|
|
The Mannheim Dream Questionnaire (MADRE)
Time Frame: from May 2023 to May 2024
|
It is a 21-items scale used to explore dream content on a 7-point Likert scale, from 0 (never) to 6 (almost every morning).
It consists of a series of structured questions aimed at investigating various aspects of the dream experience.
|
from May 2023 to May 2024
|
|
The EP worth scale (ESS)
Time Frame: from May 2023 to May 2024
|
A self-administered questionnaire, consisting of 8 items, on a 4-step Likert scale (0-3), regarding usual lifestyle habits in the recent period, aimed at exploring the presence of daytime sleepiness.
Scores ≥10 indicate excessive daytime sleepiness.
|
from May 2023 to May 2024
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: from May 2023 to May 2024
|
A self-administered tool consisting of 19 items that assesses sleep quality.
Patients can be classified as High Risk (if there are 2 or more categories in which the score is positive) or Low Risk (if there are no categories present or only one in which the score is positive), based on their responses to individual items and their overall scores in symptom categories; in addition, the 5 questions intended for the bed partner will also be included.
|
from May 2023 to May 2024
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011 Dec;15(6):343-56. doi: 10.1016/j.smrv.2011.01.003. Epub 2011 Jun 8.
- Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest. 2003 Sep;124(3):942-7. doi: 10.1378/chest.124.3.942.
- Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA, Quan SF. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res. 2016 Dec;25(6):731-738. doi: 10.1111/jsr.12430. Epub 2016 May 30.
- Chu, C. M., Wu, S. Y., Yu, C. C., & Huang, C. Y. (2021). Sleep Disturbance and Depressive Tendency in Bed Partners of Patients With Obstructive Sleep Apnea.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDG_88-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osa Syndrome
-
Mahidol UniversityCompletedOSA | COPD | Lung Function DecreasedThailand
-
Zhongnan HospitalRecruiting
-
Brigham and Women's HospitalRecruiting
-
Biocubica srlCompleted
-
Brigham and Women's HospitalRecruiting
-
Woolcock Institute of Medical ResearchFullpower Technologies, Inc.Recruiting
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Chang Gung Memorial HospitalUnknown
Clinical Trials on Continuous Positive Airway Pressure (CPAP)
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Eileen R. ChasensCompletedSleep Apnea, Obstructive | Diabetes Mellitus, Type 2United States
-
Sociedad Española de Neumología y Cirugía TorácicaCompletedObstructive Sleep ApneaSpain
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedChronic Disease | Cluster HeadacheNorway
-
McGill UniversityCentre hospitalier de l'Université de Montréal (CHUM); Philips Respironics; Multiple... and other collaboratorsCompletedObstructive Sleep Apnea-hypopnea in Multiple Sclerosis PatientsCanada
-
Chinese Pulmonary Vascular Disease Research GroupCompletedObstructive Sleep Apnea | Coronary Heart DiseaseChina
-
Eileen R. ChasensTerminatedObstructive Sleep Apnea | Type 2 DiabetesUnited States
-
Chinese University of Hong KongCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedSleep Apnea, Obstructive | Fatigue | SarcoidosisItaly
-
Hackensack Meridian HealthActive, not recruitingMild Respiratory DistressUnited States